Akso Health Group Stock Current Valuation
| AHG Stock | USD 1.26 0.04 3.28% |
Valuation analysis of Akso Health Group helps investors to measure Akso Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Akso Health's Enterprise Value Over EBITDA is most likely to increase significantly in the upcoming years. The Akso Health's current Enterprise Value Multiple is estimated to increase to 7.34, while Enterprise Value is forecasted to increase to (34.8 M). Fundamental drivers impacting Akso Health's valuation include:
Overvalued
Today
Please note that Akso Health's price fluctuation is abnormally volatile at this time. Calculation of the real value of Akso Health Group is based on 3 months time horizon. Increasing Akso Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Akso stock is determined by what a typical buyer is willing to pay for full or partial control of Akso Health Group. Since Akso Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Akso Stock. However, Akso Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.26 | Real 1.09 | Hype 1.27 | Naive 1.13 |
The real value of Akso Stock, also known as its intrinsic value, is the underlying worth of Akso Health Group Company, which is reflected in its stock price. It is based on Akso Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Akso Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Akso Health Group helps investors to forecast how Akso stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Akso Health more accurately as focusing exclusively on Akso Health's fundamentals will not take into account other important factors: Akso Health Group Company Current Valuation Analysis
Akso Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Akso Health Current Valuation | 477.66 M |
Most of Akso Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Akso Health Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Akso Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Akso Health is extremely important. It helps to project a fair market value of Akso Stock properly, considering its historical fundamentals such as Current Valuation. Since Akso Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Akso Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Akso Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Akso Health Group has a Current Valuation of 477.66 M. This is 98.54% lower than that of the Health Care Equipment & Supplies sector and 98.74% lower than that of the Health Care industry. The current valuation for all United States stocks is 97.13% higher than that of the company.
Akso Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Akso Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Akso Health could also be used in its relative valuation, which is a method of valuing Akso Health by comparing valuation metrics of similar companies.Akso Health is currently under evaluation in current valuation category among its peers.
Akso Fundamentals
| Return On Equity | -0.12 | ||||
| Return On Asset | -0.0665 | ||||
| Operating Margin | (4.16) % | ||||
| Current Valuation | 477.66 M | ||||
| Shares Outstanding | 398.82 M | ||||
| Shares Owned By Institutions | 0.07 % | ||||
| Number Of Shares Shorted | 63.66 K | ||||
| Price To Book | 3.52 X | ||||
| Price To Sales | 206.75 X | ||||
| Revenue | 2.41 M | ||||
| Gross Profit | 1.27 M | ||||
| EBITDA | (8.5 M) | ||||
| Net Income | (9.12 M) | ||||
| Cash And Equivalents | 15.46 M | ||||
| Cash Per Share | 0.68 X | ||||
| Total Debt | 2 M | ||||
| Debt To Equity | 0.61 % | ||||
| Current Ratio | 1.72 X | ||||
| Book Value Per Share | 0.95 X | ||||
| Cash Flow From Operations | 1.35 M | ||||
| Short Ratio | 0.79 X | ||||
| Earnings Per Share | (0.21) X | ||||
| Beta | 0.2 | ||||
| Market Capitalization | 350.96 M | ||||
| Total Asset | 142.02 M | ||||
| Retained Earnings | (63.93 M) | ||||
| Working Capital | 138.42 M | ||||
| Net Asset | 142.02 M |
About Akso Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Akso Health Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Akso Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Akso Health Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Akso Health Group is a strong investment it is important to analyze Akso Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Akso Health's future performance. For an informed investment choice regarding Akso Stock, refer to the following important reports:Check out Akso Health Piotroski F Score and Akso Health Altman Z Score analysis. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akso Health. If investors know Akso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akso Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.21) | Revenue Per Share | Quarterly Revenue Growth 0.148 | Return On Assets | Return On Equity |
The market value of Akso Health Group is measured differently than its book value, which is the value of Akso that is recorded on the company's balance sheet. Investors also form their own opinion of Akso Health's value that differs from its market value or its book value, called intrinsic value, which is Akso Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akso Health's market value can be influenced by many factors that don't directly affect Akso Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akso Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akso Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akso Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.